The Centers for Disease Control and Prevention has released updated infection prevention and control  for patients under investigation or with confirmed novel coronavirus (2019-nCoV) in health care settings. CDC continues to update 2019-nCoV resources for health care and public health as more is known, and urges health care partners to check its website often for updates. 

The Department of Health and Human Services today a collaboration with Regeneron Pharmaceuticals Inc. to develop a novel coronavirus treatment using multiple monoclonal antibodies, which reduce a virus’ ability to infect human cells. Meanwhile, the World Health Organization said it is sending 250,000 tests to over 70 laboratories globally for faster testing. As of today, 11 people in the U.S. have tested positive for the virus, and WHO 20,630 global cases and over 400 related deaths. 

CDC will host a series of calls with state and local partners starting Monday, Feb. 10, at 2 p.m. ET. To participate, call 1-800-857-6697, passcode 1324420. For the latest information and resources, including guidance from CDC, visit AHA’s coronavirus webpage.
 

Related News Articles

Headline
Kindergarten vaccination rates declined during the 2024-25 school year, according to data released July 31 by the Centers for Disease Control and Prevention.…
Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for…
Headline
Five pediatric flu deaths were reported to the Centers for Disease Control and Prevention last week, pushing the total to 266 for the 2024-2025 flu season,…
Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…